Tough situation after giving birth for women with type-1 diabetes

April 4, 2018, University of Gothenburg

Holding a newborn baby – and, at the same time, dealing with a blood sugar level that is fluctuating like never before. For some women with type-1 diabetes, the situation right after giving birth is overwhelming, and they need more support, according to research at Sahlgrenska Academy, Sweden.

"Of course, it's incredibly frightening if you're holding a newborn and at the same time get so dizzy that you're forced to sit down. It naturally creates fear," says Karolina Lindén, doctor in health and care sciences and registered nurse-midwife, active at the Närhälsan health care provider in Gothenburg.

A pregnancy entails higher risks to both the fetus and the mother when the mother has type-1 diabetes. In her thesis, Karolina Lindén shows that despite highly specialized care and multiple actors involved during the pregnancy, additional support may be needed after the child is born and the family has come home from the maternity ward.

In general, the in the studied group (168 individuals) were doing pretty well, but two thirds of them said that they experienced problems with instable levels after returning home from the maternity ward, of whom one fourth spoke of more difficult to manage problems. What the strong fluctuations are due to, breast-feeding or hormonal adjustments, is unclear.

Hard to take in

"They are supposed to have been given information that this can happen, but when you're pregnant and are going to give birth, focus is mainly on the delivery. It's hard to take in information about what will happen afterwards, and I believe this is true of all expectant parents," says Karolina Lindén.

In the work on her thesis, she studied well-being and diabetes management in women with type-1 diabetes during pregnancy and up to six months after the child's birth. One third of the women studied expressed a need for more professional support after the delivery. And she believes more in solutions where the women themselves do not need to take the initiative.

Follow-up over the phone, and digital appointments for the parent with a diabetes team, are variants that may work when it is difficult to get to the hospital's diabetes clinic.

A question of rights

"What's important is that a follow-up is done, and under the best of circumstances, it should be possible to identify which women need more professional support after coming home from the hospital already during the pregnancy," says Karolina Lindén.

She emphasizes that the group of expectant mothers with type-1 should not be pathologized. Basically, they are accustomed of managing their condition, and life does not circulate around it. At the same time, they are a group that rarely receives attention.

"Unfortunately, they are not always seen. But it's a question of their right to receive based on their circumstances even after the child has been born when the intensive care during the has ended," says Karolina Lindén

Explore further: Efforts are needed to help pregnant women with diabetes

More information: Women with type 1 diabetes during pregnancy and postpartum Well-being and diabetes management; hdl.handle.net/2077/54536

Related Stories

Efforts are needed to help pregnant women with diabetes

February 15, 2018
Researchers who analyzed data from the UK's National Pregnancy in Diabetes Audit found concerning shortcomings in pregnancy preparation and prenatal care for women with diabetes. In addition, significant clinic-to-clinic ...

AI application for treatment of gestational diabetes

March 8, 2018
AI allows individualized predictions for expectant mothers and newborn children. The aim of the individual recommendations is a positive experience for the user combined with activity that is beneficial for the glucose level.

Health Check—is it safe to express milk before giving birth?

June 2, 2017
Late in their pregnancies, some women notice colostrum (early milk) leaking from their nipples.

Higher blood sugar in early pregnancy raises baby's heart-defect risk

December 15, 2017
Higher blood sugar early in pregnancy raises the baby's risk of a congenital heart defect, even among mothers who do not have diabetes, according to a study led by researchers at the Stanford University School of Medicine.

Better monitoring needed for pregnant women with diabetes

November 14, 2017
Half the babies born to women with diabetes are at risk of suffering complications due to fluctuations in their mothers' glucose levels, say researchers.

Diabetes, but not diabetes drug, linked to poor pregnancy outcomes

December 20, 2017
New research indicates that pregnant women with pre-gestational diabetes who take metformin are at a higher risk for adverse pregnancy outcomes—such as major birth defects and pregnancy loss—than the general population, ...

Recommended for you

Implantable islet cells come with their own oxygen supply

April 25, 2018
Since the 1960s, researchers have been interested in the possibility of treating type 1 diabetes by transplanting islet cells—the pancreatic cells that are responsible for producing insulin when blood glucose concentration ...

Study shows drug effectiveness in reducing glucocorticoid-induced bone loss

April 25, 2018
About one in every 100 people in the world takes glucocorticoids long term to treat immune-mediated diseases. However, glucocorticoids, such as prednisone, have a side effect—they induce the bone loss called osteoporosis, ...

Bariatric surgery successes lead to type 2 diabetes treatment

April 24, 2018
Bariatric surgery has long yielded almost immediate health benefits for patients with type 2 diabetes, and new findings on the reasons for remission may be the key to developing drug alternatives to surgery.

Hacking human 'drug trafficking' network could make diabetes treatments more effective

April 23, 2018
Making tiny changes to existing diabetes treatments can alter how they interact with cells, and potentially make the medicines more effective.

Vitamin D deficiency linked to greater risk of diabetes

April 19, 2018
An epidemiological study conducted by researchers at University of California San Diego School of Medicine and Seoul National University suggests that persons deficient in vitamin D may be at much greater risk of developing ...

One class of drug used to treat type 2 diabetes may not reduce the risk of death when compared with placebo

April 17, 2018
One class of drug used to treat type 2 diabetes may not reduce the risk of death when compared with placebo, suggests new findings.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.